NO951765D0 - Transdermalt terapeutisk system for frigjöring av 17. radiol og fremgangsmåte for fremstilling derav - Google Patents

Transdermalt terapeutisk system for frigjöring av 17. radiol og fremgangsmåte for fremstilling derav

Info

Publication number
NO951765D0
NO951765D0 NO951765A NO951765A NO951765D0 NO 951765 D0 NO951765 D0 NO 951765D0 NO 951765 A NO951765 A NO 951765A NO 951765 A NO951765 A NO 951765A NO 951765 D0 NO951765 D0 NO 951765D0
Authority
NO
Norway
Prior art keywords
adhesive layer
therapeutic system
transdermal therapeutic
matrix layers
radiol
Prior art date
Application number
NO951765A
Other languages
English (en)
Other versions
NO951765L (no
NO311783B1 (no
Inventor
Michael Horstmann
Sylvia Hahn
Reinhold Meconi
Robert-Peter Klein
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6472230&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO951765(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO951765L publication Critical patent/NO951765L/no
Publication of NO951765D0 publication Critical patent/NO951765D0/no
Publication of NO311783B1 publication Critical patent/NO311783B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO19951765A 1992-11-06 1995-05-05 Transdermalt terapeutisk system for frigjöring av 17-<beta>- östradiol og fremgangsmåte for fremstilling derav NO311783B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4237453A DE4237453C1 (no) 1992-11-06 1992-11-06
PCT/EP1993/002971 WO1994010984A1 (de) 1992-11-06 1993-10-27 TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR ABGABE VON 17-β-ESTRADIOL UND VERFAHREN ZU SEINER HERSTELLUNG

Publications (3)

Publication Number Publication Date
NO951765L NO951765L (no) 1995-05-05
NO951765D0 true NO951765D0 (no) 1995-05-05
NO311783B1 NO311783B1 (no) 2002-01-28

Family

ID=6472230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19951765A NO311783B1 (no) 1992-11-06 1995-05-05 Transdermalt terapeutisk system for frigjöring av 17-<beta>- östradiol og fremgangsmåte for fremstilling derav

Country Status (24)

Country Link
US (1) US5912008A (no)
EP (1) EP0716599B1 (no)
JP (1) JP3237016B2 (no)
KR (1) KR100306946B1 (no)
AT (1) ATE164516T1 (no)
AU (1) AU678408B2 (no)
CA (1) CA2147172C (no)
CZ (1) CZ286907B6 (no)
DE (2) DE4237453C1 (no)
DK (1) DK0716599T3 (no)
ES (1) ES2117152T3 (no)
FI (1) FI113339B (no)
HR (1) HRP931360B1 (no)
HU (1) HU221847B1 (no)
IL (1) IL107395A (no)
MY (1) MY118171A (no)
NO (1) NO311783B1 (no)
NZ (1) NZ257137A (no)
PL (1) PL174604B1 (no)
SI (1) SI9300581A (no)
SK (1) SK279911B6 (no)
WO (1) WO1994010984A1 (no)
YU (1) YU69693A (no)
ZA (1) ZA938257B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2060148T3 (es) * 1989-02-28 1994-11-16 Teijin Ltd Cataplasma y su preparacion.
CA2161004C (en) * 1993-04-20 2004-10-26 Wilfried Fischer Active ingredient patch
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
JP4399044B2 (ja) * 1998-10-14 2010-01-13 久光製薬株式会社 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤
US6631186B1 (en) * 1999-04-09 2003-10-07 Sbc Technology Resources, Inc. System and method for implementing and accessing call forwarding services
DE19925613A1 (de) 1999-06-04 2000-12-07 Lohmann Therapie Syst Lts Verbundlaminat und Verfahren zu seiner Herstellung
ITRM20060440A1 (it) * 2006-08-10 2008-02-11 Carmine Antropoli Uso della nifedipina per il trattamento antirughe
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
JP6277124B2 (ja) * 2011-07-05 2018-02-07 ノヴァン，インコーポレイテッド 局所用組成物
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
WO2016007834A1 (en) 2014-07-11 2016-01-14 Novan, Inc. Topical antiviral compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
EP3442502A4 (en) 2016-04-13 2019-11-06 Novan, Inc. COMPOSITIONS, SYSTEMS, KITS AND METHODS FOR TREATING INFECTION
DE102017127433A1 (de) 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR527450A (fr) * 1919-12-04 1921-10-25 Gilbert Mahaut Système et dispositif pour la combustion des huiles lourdes dans les foyers industriels et autres
US4435180A (en) * 1982-05-25 1984-03-06 Alza Corporation Elastomeric active agent delivery system and method of use
GB2138286B (en) * 1983-04-19 1986-10-08 Dr Christopher Harry Mortimer Pharmaceutical composition for the treatment of hair loss
DE3587616D1 (de) * 1984-12-22 1993-11-11 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster.
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
ES2060148T3 (es) * 1989-02-28 1994-11-16 Teijin Ltd Cataplasma y su preparacion.
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
CA2066249C (en) * 1990-05-17 1997-12-16 Akira Nakagawa Estradiol percutaneous administration preparations

Also Published As

Publication number Publication date
WO1994010984A1 (de) 1994-05-26
CZ116295A3 (en) 1995-12-13
FI952115A (fi) 1995-05-03
ZA938257B (en) 1994-06-08
MY118171A (en) 2004-09-30
IL107395A (en) 1997-08-14
CA2147172C (en) 2003-12-23
NO951765L (no) 1995-05-05
FI113339B (fi) 2004-04-15
DK0716599T3 (da) 1999-01-11
DE59308360D1 (de) 1998-05-07
KR950703940A (ko) 1995-11-17
ATE164516T1 (de) 1998-04-15
NO311783B1 (no) 2002-01-28
HRP931360B1 (en) 1999-12-31
HUT71681A (en) 1996-01-29
DE4237453C1 (no) 1993-08-19
AU678408B2 (en) 1997-05-29
NZ257137A (en) 1996-09-25
HU9501318D0 (en) 1995-06-28
HRP931360A2 (en) 1995-02-28
JP3237016B2 (ja) 2001-12-10
FI952115A0 (fi) 1995-05-03
YU69693A (sh) 1997-07-31
PL308532A1 (en) 1995-08-21
KR100306946B1 (ko) 2002-04-24
SK58095A3 (en) 1995-11-08
SK279911B6 (sk) 1999-05-07
HU221847B1 (hu) 2003-02-28
US5912008A (en) 1999-06-15
JPH08502987A (ja) 1996-04-02
EP0716599B1 (de) 1998-04-01
AU5338694A (en) 1994-06-08
IL107395A0 (en) 1994-01-25
CA2147172A1 (en) 1994-05-26
EP0716599A1 (de) 1996-06-19
ES2117152T3 (es) 1998-08-01
SI9300581A (en) 1994-06-30
CZ286907B6 (en) 2000-08-16
PL174604B1 (pl) 1998-08-31

Similar Documents

Publication Publication Date Title
NO951765L (no) Transdermalt terapeutisk system for frigjöring av 17. radiol og fremgangsmåte for fremstilling derav
NO900748D0 (no) Terapeutisk system for retardert og kontrollert transdermal eller transslimhinne administrering av aktive substanser (ii).
FI950165A (fi) Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena on 17-beta-estradioli (vedetön)
IL125160A (en) Transdermal therapeutic composition, process for its preparation and use thereof
IL114949A0 (en) A transdermal layered therapeutic system containing estradiol and a process for the preparation thereof

Legal Events

Date Code Title Description
MK1K Patent expired